Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2018

View Archived Issues

Avillion enters agreement to develop PT-027 for asthma

First patient dosed in phase I study of Affibody's ABY-039

Merus said that Ono Pharmaceutical enter new research and license agreement

IL-32 isoforms tied to cardiovascular disease in HIV-infected individuals

Inovio Pharmaceuticals reports interim results from phase I study of DNA immunotherapy for HBV

FDA accepts IND for phase II study of SM-88 in pancreatic cancer

Jupiter Orphan Therapeutics submits IND in U.S. for Jotrol

Initiation of phase I trial to evaluate VLA-1553 vaccine candidate against Chikungunya

Savara begins OPTIMA study of Molgradex, ceases development of Aironite

OxThera initiates phase III study of Oxabact in primary hyperoxaluria

3BNC117 and 10-1074 antibody combination shows promise for HIV infection

Ionis opens enrollment in phase II trial of IONIS-FB-LRX in GA secondary to AMD

ImmunoRestoration enters license agreement with University of Pennsylvania

Medshine Discovery patents new PDE4 inhibitors

Arrowhead initiates phase I/IIa trial of ARO-HBV for hepatitis B

FDA accepts sBLA for Xeomin

Interim ANNEXA-4 data show high rate of hemostasis with andexanet alfa

Nanchang Helioeast Pharmaceutical presents novel TKIs

FDA places clinical hold on phase I/II trial of SGT-001 for Duchenne muscular dystrophy

CSL Behring studies safety of CSL-730 in healthy Caucasian and Japanese subjects

Japanese researchers disclose PDE7 inhibitors

FDA awards fast track designation to Destiny Pharma's exeporfinium chloride

University of Michigan discovers Bcr-Abl kinase inhibitors

3M Innovative Properties cytokine-production inducers

Exosome Diagnostics collaborates with Intezyne on assay for use in IT-139 trials

Novel AC5 inhibitor for treating myocardial infarction shows promise

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...